ArticleBritish journal of haematology2022

Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients.

Sara Harrysson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.